(5S)-2,2-DIOXIDO-5-METHYL-1,2,3-OXATHIAZOLIDINE, N-BOC PROTECTED, 95.0%, 50g

3-Phenoxyphenol, 95.0%, 10g

8-(1,3,4-OXADIAZOL-2-YL)-2,4-BIS(TRIFLUOROMETHYL)IMIDAZO[1,2-A][1,8]NAPHTHYRIDINE, 90%, 1g

1-(Cyclopropylmethyl)-5-(trifluoromethyl)-1H-pyrazole-3-carboxylic acid, >95%, 1g

1,1,1,3,5,7,7,7-Octamethyltetrasiloxane>95.0%(GC)5g

1-(3-Hydroxypropyl)-4-methylpiperazine, 98.0%, 25g

((1S,4R)-4-(2-Amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol hydrochloride, 95.0%, 100g

5-Bromo-2,3-dihydro-1-benzofuran-2-one, 97%, 250mg

(R)-2,2,2-Trifluoro-1-phenylethylaminehydrochloride, 95.0%, 5g

Ethyl 2-bromo-5-fluorobenzoate, 95.0%, 100g

2-Chloro-5-phenyl-1,3,4-oxadiazole, 95.0%, 250mg

3-Fluorobenzoic acid, 98.0%, 1kg

(S)-(+)-2,2,2-Trifluoro-1-(9-anthryl)ethanol [e.e. Determination Reagent by NMR]>99.0%(GC)1g